Safe use of intravesical bacillus Calmette-Guérin immunotherapy for bladder cancer during breastfeeding: a case report.
Immunotherapy
; 14(10): 759-764, 2022 07.
Article
en En
| MEDLINE
| ID: mdl-35754395
Bacillus Calmette-Guérin (BCG) is tuberculosis vaccine. It contains live but attenuated tubercle bacillus. It is also used for bladder cancer treatment, where it is directly instilled into the bladder. BCG activates the local immune response within the bladder to fight cancer cells. The issue of whether BCG instillations into the bladder cause the bacillus to be excreted in breast milk in a lactating woman remains unknown. The US FDA suggests discontinuing breastfeeding when undergoing treatment with BCG due to potential adverse reactions. The authors report on a breastfeeding woman with bladder cancer who elected to receive BCG immunotherapy. The baby received a precautionary dermal BCG vaccination 2 weeks before the patient's treatment. Ultimately, she was able to complete her treatment while breastfeeding her child without any negative effects on the infant or herself. To the best of the authors' knowledge, this is the first article showing that breastfeeding may be safe during BCG treatment for bladder cancer.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Neoplasias de la Vejiga Urinaria
/
Vacuna BCG
/
Carcinoma de Células Transicionales
/
Inmunoterapia
Límite:
Adult
/
Female
/
Humans
/
Newborn
Idioma:
En
Revista:
Immunotherapy
Asunto de la revista:
ALERGIA E IMUNOLOGIA
/
TERAPEUTICA
Año:
2022
Tipo del documento:
Article
País de afiliación:
Turquía
Pais de publicación:
Reino Unido